Archontia Kaminari

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Papillary Thyroid

Molecularly Imprinted

Dna Damage Response

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Venturina Stagni, Archontia Kaminari, Claudia Contadini, Daniela Barilà, Rosario Luigi Sessa, Zili Sideratou, Spiros A Vlahopoulos, Dimitris Tsiourvas
A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres. Cancers 15 (5) (2023)
Barbara Mavroidi, Archontia Kaminari, Elias Sakellis, Zili Sideratou, Dimitris Tsiourvas
Carbon Dots-Biomembrane Interactions and Their Implications for Cellular Drug Delivery. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Barbara Mavroidi, Archontia Kaminari, Elias Sakellis, Zili Sideratou, Dimitris Tsiourvas
Carbon Dots-Biomembrane Interactions and Their Implications for Cellular Drug Delivery. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Venturina Stagni, Archontia Kaminari, Claudia Contadini, Daniela Barilà, Rosario Luigi Sessa, Zili Sideratou, Spiros A Vlahopoulos, Dimitris Tsiourvas
A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres. Cancers 15 (5) (2023)
Barbara Mavroidi, Archontia Kaminari, Dimitris Matiadis, Dimitra Hadjipavlou-Litina, Maria Pelecanou, Athina Tzinia, Marina Sagnou
The Prophylactic and Multimodal Activity of Two Isatin Thiosemicarbazones against Alzheimer's Disease In Vitro. Brain sciences 12 (6) (2022)
Archontia Kaminari, Eleni Nikoli, Alexandros Athanasopoulos, Elias Sakellis, Zili Sideratou, Dimitris Tsiourvas
Engineering Mitochondriotropic Carbon Dots for Targeting Cancer Cells. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)